HUTCHMED (China) Limited (AIM:HCM)
202.00
-4.00 (-1.94%)
Mar 5, 2026, 4:40 PM GMT
HUTCHMED (China) Employees
HUTCHMED (China) had 1,811 employees as of December 31, 2024. The number of employees decreased by 177 or -8.90% compared to the previous year.
Employees
1,811
Change (1Y)
-177
Growth (1Y)
-8.90%
Revenue / Employee
228.96K GBP
Profits / Employee
190.72K GBP
Market Cap
1.77B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Hikma Pharmaceuticals | 9,500 |
| Allergy Therapeutics | 584 |
| Animalcare Group | 201 |
| Shield Therapeutics | 63 |
| Haleon | 24,561 |
| Venture Life Group | 43 |
| ECO Animal Health Group | 200 |
| Provexis | 2 |
HUTCHMED (China) News
- 1 day ago - An Overview of HUTCHMED (China)'s Earnings - Benzinga
- 27 days ago - HUTCHMED to Announce 2025 Final Results - GlobeNewsWire
- 4 weeks ago - HUTCHMED (China) Ltd (HCM) Stock Price Down 3.53% on Feb 2 - GuruFocus
- 7 weeks ago - HUTCHMED Highlights Publication of Phase III SACHI Results in The Lancet - GlobeNewsWire
- 2 months ago - Positive China Trial Data Moves HUTCHMED Closer To Rare Blood Disorder Drug Filing In 2026 - Benzinga
- 2 months ago - Positive China Trial Data Moves HUTCHMED Closer To Rare Blood Disorder Drug Filing In 2026 - Benzinga
- 2 months ago - HUTCHMED's ESLIM-02 Trial Of Sovleplenib In Warm Autoimmune Hemolytic Anemia Meets Key Goal - Nasdaq
- 2 months ago - HUTCHMED's Sovleplenib Reaches Phase III Goal In Warm Autoimmune Hemolytic Anemia Trial In China - Nasdaq